PYOTT DAVID E I
SEC insider (Form 3/4/5 filer). CIK 0001051578. Director at Tarsus Pharmaceuticals, Inc. (TARS) and 2 other issuers. 18 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in IRVINE, CA.
Companies PYOTT DAVID E I has filed insider reports for
- Tarsus Pharmaceuticals, Inc. (TARS): Director
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Director
- PLIANT THERAPEUTICS, INC. (PLRX): Director
PYOTT DAVID E I
CIK: 0001051578
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Sep 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
ExerciseIndirect201 shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
806 shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
3.8K shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
2.4K shares- - Jun 1, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
ExerciseDirect3.8K shares- - Jun 1, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect921 shares at avg. $297.71$274K - Jun 1, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect1.2K shares at avg. $298.91$351K - Jun 1, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect1.2K shares at avg. $299.87$366K - Jun 1, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect495 shares at avg. $300.72$149K - Jun 1, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect17 shares at avg. $302.65$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 |  TARS Tarsus Pharmaceuticals, Inc. | Exercise | 201 | - | $0 | Indirect |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 806 | - | - | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 3,837 | - | - | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 2,417 | - | - | Direct |
| Jun 1, 2026 |  ALNY ALNYLAM PHARMACEUTICALS, INC. | Exercise | 3,830 | - | $0 | Direct |
| Jun 1, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 921 | $297.71 | $274,191 | Direct |
| Jun 1, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 1,175 | $298.91 | $351,219 | Direct |
| Jun 1, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 1,222 | $299.87 | $366,441 | Direct |
| Jun 1, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 495 | $300.72 | $148,856 | Direct |
| Jun 1, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 17 | $302.65 | $5,145 | Direct |
1-10 of 18 transactions